These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 21105575)
1. Cellular uptake and elimination of lipophilic drug delivered by nanocarriers. Sun X; Li F; Wang Y; Liang W Pharmazie; 2010 Oct; 65(10):737-42. PubMed ID: 21105575 [TBL] [Abstract][Full Text] [Related]
2. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372 [TBL] [Abstract][Full Text] [Related]
3. [Effects of sub-micro emulsion composition on cellular disposition of incorporated lipophilic drug]. Sun XY; Xiang ZQ; Wu S; Lv YY; Liang WQ Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):523-9. PubMed ID: 24167133 [TBL] [Abstract][Full Text] [Related]
4. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223 [TBL] [Abstract][Full Text] [Related]
5. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519 [TBL] [Abstract][Full Text] [Related]
6. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. Rivolta I; Panariti A; Lettiero B; Sesana S; Gasco P; Gasco MR; Masserini M; Miserocchi G J Physiol Pharmacol; 2011 Feb; 62(1):45-53. PubMed ID: 21451209 [TBL] [Abstract][Full Text] [Related]
7. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells. Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
9. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles. Gao X; Wang T; Wu B; Chen J; Chen J; Yue Y; Dai N; Chen H; Jiang X Biochem Biophys Res Commun; 2008 Dec; 377(1):35-40. PubMed ID: 18823949 [TBL] [Abstract][Full Text] [Related]
10. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779 [TBL] [Abstract][Full Text] [Related]
11. UEA I-bearing nanoparticles for brain delivery following intranasal administration. Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948 [TBL] [Abstract][Full Text] [Related]
12. A novel fluorescent probe for more effective monitoring of nanosized drug delivery systems within the cells. Plajnšek KT; Pajk S; Govedarica B; Pečar S; Srčič S; Kristl J Int J Pharm; 2011 Sep; 416(1):384-93. PubMed ID: 21745558 [TBL] [Abstract][Full Text] [Related]
13. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
14. Efficiency of cytoplasmic delivery by non-cationic liposomes to cells in vitro: a confocal laser scanning microscopy study. Mady MM; Ghannam MM; Khalil WA; Müller R; Fahr A Phys Med; 2009 Jun; 25(2):88-93. PubMed ID: 18590977 [TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration. Inokuchi Y; Hironaka K; Fujisawa T; Tozuka Y; Tsuruma K; Shimazawa M; Takeuchi H; Hara H Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3162-70. PubMed ID: 20053972 [TBL] [Abstract][Full Text] [Related]
16. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Budhian A; Siegel SJ; Winey KI Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944 [TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin. Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924 [TBL] [Abstract][Full Text] [Related]
18. Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Weiss CK; Lorenz MR; Landfester K; Mailänder V Macromol Biosci; 2007 Jul; 7(7):883-96. PubMed ID: 17595680 [TBL] [Abstract][Full Text] [Related]
19. Disaccharide-modified liposomes and their in vitro intracellular uptake. Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometry as a new approach to investigate drug transfer between lipid particles. Petersen S; Fahr A; Bunjes H Mol Pharm; 2010 Apr; 7(2):350-63. PubMed ID: 20063898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]